Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.15 -0.09 (-7.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Gains from Sales and Divestitures (2017 - 2021)

Updated

Tvardi Therapeutics' Gains from Sales and Divestitures was $70,000 in FY2021.

Analysis

Tvardi Therapeutics (TVRD) Gains from Sales and Divestitures (2017 - 2021) Analysis & Trends

From FY2012 onward, Tvardi Therapeutics has reported Gains from Sales and Divestitures for 4 years.

  • Gains from Sales and Divestitures shows a four-year compound annual growth rate of 14.3% (FY2017 to FY2021).
  • The FY2021 figure marks the lowest annual Gains from Sales and Divestitures since FY2017.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was $41,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tvardi Therapeutics 10.79 Mn 10.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 70,000.00
Sep 30, 2017 28,000.00
API Access

Tvardi Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TVRD&period=max&api_key=YOUR_API_KEY